Viewing Study NCT02779569


Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2026-01-25 @ 10:48 PM
Study NCT ID: NCT02779569
Status: UNKNOWN
Last Update Posted: 2017-11-08
First Post: 2016-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Trial Evaluating the Efficacy of Ultra Low Dose of Decitabine in Myelodysplastic Syndromes (MDS)
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-03
Start Date Type: None
Primary Completion Date: 2019-03
Primary Completion Date Type: ESTIMATED
Completion Date: 2019-08
Completion Date Type: ESTIMATED
First Submit Date: 2016-05-09
First Submit QC Date: None
Study First Post Date: 2016-05-20
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-11-07
Last Update Post Date: 2017-11-08
Last Update Post Date Type: ACTUAL